Harish Ahuja, MD
Hematology & Oncology · Fargo, NDNPI 1841201746
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,853 of the $26,399 with a category attached, or 63.8%. 34 manufacturers reported payments, led by Gilead at 37.2% of the total. Reporting peaked in 2019 at $11,452 and has fallen 92.8% since, to $821 in 2025. Among hematology & oncology clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $219.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$10K
- AstraZeneca$5K
- Kyowa Kirin, Inc.$4K
- Taiho Oncology, Inc.$3K
- Johnson & Johnson$2K
- Tempus AI, Inc$339
- plus $2K from 28 others
Across 17 payments — averaging $3268.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$43K
- Amgen$9K
- Merck$3K
What the payments were for
- Consulting fees$16,85364%
- Speaking & faculty fees$4502%
- Travel & lodging$5,76222%
- Food & beverage$3,19712%
- Education$1381%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead(2 entities) | 23 | $9,822 |
| AstraZeneca(2 entities) | 11 | $4,807 |
| Kyowa Kirin, Inc. | 10 | $4,373 |
| Taiho Oncology, Inc. | 14 | $3,457 |
| Johnson & Johnson | 2 | $1,585 |
| Tempus AI, Inc | 7 | $339 |
| Daiichi Sankyo Inc. | 3 | $282 |
| Novocure GmbH | 1 | $250 |
| Merck | 5 | $193 |
| Novartis | 8 | $182 |
| AVEO Pharmaceuticals, Inc. | 2 | $131 |
| Astellas Pharma US Inc | 1 | $120 |
| Comsort, Inc | 1 | $100 |
| Pfizer | 3 | $71 |
| E.r. Squibb & Sons, L.L.C. | 3 | $66 |
| Deciphera Pharmaceuticals Inc. | 2 | $60 |
| Boehringer Ingelheim | 2 | $51 |
| Bayer | 2 | $49 |
| AbbVie | 2 | $48 |
| GSK | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Myriad Genetic Laboratories, Inc. | 1 | $33 |
| Array Biopharma Inc | 1 | $29 |
| Puma Biotechnology, Inc. | 1 | $29 |
| Acrotech Biopharma Inc. | 2 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| ADC Therapeutics America, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $20 |
| Genmab U.S., Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,399 in reported general payments places this provider in the 90th percentile of 35 hematology & oncology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 13 | $165 |
| Prednisone | 12 | $85 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Fargo
- Mahendra GuptaFargo$96K
- Radha Krishna VeguntaFargo$37K
- Michael DurandoFargo$2K
- Daniel AlmquistFargo$620
- Jeffrey WiisanenFargo$444
- Richard SheppardFargo$410
- Julia ParrishFargo$401
- Anu GabaFargo$366
- Howard RussellFargo$254
- Gerald GrossFargo$173
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.